CCG
EBS icon

Chatham Capital Group’s Emergent Biosolutions EBS Stock Holding History

Chatham Capital Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,260
Closed -$2.53M – 192
2021
Q1 		$2.53M Buy
27,260
+1,225
+5% +$125K 0.53% 62
2020
Q4 		$2.33M Buy
26,035
+27
+0.1% +$2.48K 0.52% 57
2020
Q3 		$2.69M Sell
26,008
-269
-1% -$29K 0.66% 44
2020
Q2 		$2.08M Buy
26,277
+134
+0.5% +$9.99K 0.54% 52
2020
Q1 		$1.51M Sell
26,143
-477
-2% -$27.5K 0.45% 54
2019
Q4 		$1.44M Buy
26,620
+48
+0.2% +$2.6K 0.35% 80
2019
Q3 		$1.39M Sell
26,572
-130
-0.5% -$6.06K 0.35% 74
2019
Q2 		$1.29M Sell
26,702
-110
-0.4% -$5.27K 0.32% 85
2019
Q1 		$1.35M Buy
26,812
+5,789
+28% +$341K 0.35% 80
2018
Q4 		$1.25M Buy
21,023
+2,118
+11% +$137K 0.35% 74
2018
Q3 		$1.25M Hold
18,905
– – 0.31% 77
2018
Q2 		$955K Buy
18,905
+425
+2% +$22.1K 0.25% 86
2018
Q1 		$973K Sell
18,480
-600
-3% -$29.9K 0.26% 82
2017
Q4 		$887K Buy
19,080
+180
+1% +$7.58K 0.24% 82
2017
Q3 		$765K Hold
18,900
– – 0.22% 93
2017
Q2 		$641K Buy
+18,900
New +$583K 0.18% 102

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chatham Capital Group's EBS Position: Q2 2021 in Review

Chatham Capital Group sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 27,260 shares — an estimated $2.53M sold.

Chatham Capital Group first reported a position in EBS in Q2 2017 and held it in 16 quarters. The position peaked at $2.69M in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Chatham Capital Group reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Chatham Capital Group sold 27,260 Emergent Biosolutions shares in Q2 2021, an estimated $2.53M.
  • Chatham Capital Group first reported a position in Emergent Biosolutions in Q2 2017 and held it in 16 quarters.
  • Chatham Capital Group's Emergent Biosolutions position peaked at $2.69M in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Chatham Capital Group's 13F filing for Q2 2021, filed 28 Jul 2021.